54 related articles for article (PubMed ID: 7422530)
1. Effects of vasodilators on renal function in severe heart failure.
Mantle JA; Russell RO; Tauxe WN; Dustan HP; Rogers WJ; Rackley CE
Nouv Presse Med; 1980 Sep; 9(34 Suppl):2399-403. PubMed ID: 7422530
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of congestive cardiac failure with vasodilators (author's transl)].
Hauf GF; Bubenheimer P; Lönne E; Roskamm H
Dtsch Med Wochenschr; 1981 Nov; 106(48):1607-12. PubMed ID: 7307999
[TBL] [Abstract][Full Text] [Related]
3. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
Mahgoub AA; El-Medany AH; Abdulatif AS
Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
[TBL] [Abstract][Full Text] [Related]
4. Importance of venodilation during long-term vasodilator therapy of chronic left ventricular failure.
Franciosa JA; Leddy CL; Schwartz DE
Z Kardiol; 1983; 72 Suppl 3():168-72. PubMed ID: 6666217
[TBL] [Abstract][Full Text] [Related]
5. Postural influences on the hemodynamic responses to vasodilating drugs in congestive heart failure.
Ren JH; Unverferth DV; Magorien RD; Leier CV
Arch Intern Med; 1985 Apr; 145(4):641-4. PubMed ID: 3985726
[TBL] [Abstract][Full Text] [Related]
6. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
Olsen NV
Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
[TBL] [Abstract][Full Text] [Related]
7. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
[TBL] [Abstract][Full Text] [Related]
8. Peripheral resistances in acute myocardial infarction: the use of prazosine versus isosorbide dinitrate.
Costa PP; Permutti B; Fernandes P; Croce G
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):208-11. PubMed ID: 7390671
[TBL] [Abstract][Full Text] [Related]
9. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
Miller RR; Awan NA; Maxwell KS; Mason DT
N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
[TBL] [Abstract][Full Text] [Related]
10. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
[TBL] [Abstract][Full Text] [Related]
11. Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
Prescrire Int; 2011 Jun; 20(117):156-60. PubMed ID: 21678708
[TBL] [Abstract][Full Text] [Related]
12. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
[TBL] [Abstract][Full Text] [Related]
13. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
[TBL] [Abstract][Full Text] [Related]
14. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure.
Al-Hesayen A; Parker JD
Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026
[TBL] [Abstract][Full Text] [Related]
15. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
16. Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.
Zhao G; Messina E; Xu X; Ochoa M; Serpillon S; Shryock J; Belardinelli L; Hintze TH
Eur J Pharmacol; 2006 Jul; 541(3):171-6. PubMed ID: 16777088
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular adaptation to orthostatic stress during vasodilator therapy.
Lipsitz LA; Connelly CM; Kelley-Gagnon M; Kiely DK; Abernethy D; Waksmonski C
Clin Pharmacol Ther; 1996 Oct; 60(4):461-71. PubMed ID: 8873694
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
Xu XW; Zeng GY; Yang Y; Liu HX
Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
[TBL] [Abstract][Full Text] [Related]
19. Early and medium term results of tailored therapy for heart failure.
Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM
Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic effects of isosorbide-5-mononitrate administration on effective renal plasma flow and the renin-aldosterone system in cirrhotic patients.
Chen SD; Hsieh JF; Tsai SC; Lin WY
J Gastroenterol Hepatol; 2000 Sep; 15(9):1059-63. PubMed ID: 11059938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
